Medical Devices Philippines

Philippines Alzheimer's Blood Tests Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Philippines Alzheimer's Blood Tests Market Industry Trends and Forecast to 2034: Segmented by (Biomarker, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Philippines · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $0.9 Mn Placeholder estimate
Estimate 2025 $1.1 Mn 0.2% of the global market
Projected 2034 $8.2 Mn 650.4% Adds $7.1 Mn over 9 forecast years
CAGR 2025–2034 25.1% Faster than 96% of 193 Medical Devices markets here
Key players 5
  • Philippines is 0.23% of the global market.
  • In APAC, the largest is China at $40.2 Mn.
  • Fastest growing: India at 27.9% a year.
  • Philippines ranks 6th of 10 by size in APAC.

Market size projection

Philippines

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$7.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Alzheimer's Blood Tests Market market size by year, Philippines
YearMarket sizeChange that yearSince 2025
2024 (estimate) $0.9 Mn — —
2025 (base) $1.1 Mn +$0.2 Mn —
2026 (forecast) $1.4 Mn +$0.3 Mn +25.1%
2027 (forecast) $1.7 Mn +$0.3 Mn +56.5%
2028 (forecast) $2.1 Mn +$0.4 Mn +95.8%
2029 (forecast) $2.7 Mn +$0.5 Mn +144.9%
2030 (forecast) $3.4 Mn +$0.7 Mn +206.4%
2031 (forecast) $4.2 Mn +$0.8 Mn +283.3%
2032 (forecast) $5.3 Mn +$1.1 Mn +379.5%
2033 (forecast) $6.6 Mn +$1.3 Mn +499.9%
2034 (forecast) $8.2 Mn +$1.6 Mn +650.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Philippines Alzheimer's Blood Tests Market Analysis at a glance
Market size, 2025$1.1 Mn placeholder estimate
Forecast, 2034$8.2 Mn placeholder estimate
Growth (CAGR), 2025–203425.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledBlood-Based Biomarkers for Alzheimer's Disease
SegmentsBiomarker, use and end user (see all)
Key playersC2N Diagnostics, Roche Diagnostics, Fujirebio, Quanterix, Quest Diagnostics (see all)
Regulator in the PhilippinesFDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Philippines Alzheimer's Blood Tests Market Analysis Executive Summary

Alzheimer's blood tests measure proteins such as p-tau and amyloid in blood to help diagnose Alzheimer's disease without a brain scan.

Key segments of the alzheimer's Blood Tests market include biomarker (p-Tau217, Amyloid Beta 42/40 and Neurofilament Light) and use (Diagnosis, Clinical Trial Screening and Monitoring).

Bar chart: Philippines Alzheimer's Blood Tests market size, 2024–2034, placeholder estimates. $0.9 Mn in 2024, $1.1 Mn in 2025 and $8.2 Mn in 2034, 25.1% CAGR.
Philippines Alzheimer's Blood Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Philippines Alzheimer's Blood Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the alzheimer's Blood Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the alzheimer's Blood Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the alzheimer's Blood Tests market.

Competitive Landscape for Alzheimer's Blood Tests Market in the Philippines

The alzheimer's Blood Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Alzheimer's Blood Tests Market in the Philippines

Alzheimer's Blood Tests in the Philippines: rules and payment

Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA).⁠[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.⁠[2]

[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[2] PhilHealth. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how alzheimer's Blood Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the Philippines.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Alzheimer's Blood Tests right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Alzheimer's Blood Tests in context

The Philippines compared

  • Health spending per person: 194 US$ per person (2023). World: 1,317 US$ per person (2023). 10th highest of the 17 countries we cover in APAC.[1]
  • Doctors: 0.79 per 1,000 people (2021). World: 1.86 per 1,000 people (2022). 11th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 5.7% of people (2025). World: 10.4% of people (2025). 16th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Alzheimer's Blood Tests market in the Philippines?
Placeholder estimate: about $1.1 Mn in 2025, rising to about $8.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Alzheimer's Blood Tests market in the Philippines growing?
Placeholder estimate: about 25.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Alzheimer's Blood Tests market report cover?
The report splits the market by biomarker (p-Tau217, Amyloid Beta 42/40, Neurofilament Light), use (Diagnosis, Clinical Trial Screening, Monitoring) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Alzheimer's Blood Tests market?
Key players include C2N Diagnostics, Roche Diagnostics, Fujirebio, Quanterix and Quest Diagnostics.
What is driving the Alzheimer's Blood Tests market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the alzheimer's Blood Tests market.
Who regulates Alzheimer's Blood Tests in the Philippines?
Medical devices need registration or notification with the Food and Drug Administration of the Philippines (FDA). Source: Food and Drug Administration Philippines. Checked 14 Nov 2026.
How is healthcare paid for in the Philippines?
PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member. Source: PhilHealth. Checked 14 Nov 2026.
How much research is published on Alzheimer's Blood Tests?
PubMed lists 504 papers on Alzheimer's Blood Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Philippines

See all

Related on diagnostics and lab testing and alzheimer's

See the topic